Optimal temperature of continuous lidocaine perfusion for the heart preservation

被引:5
作者
Mitsuru Asano
Koichi Inoue
Susumu Ando
Atsushi Bito
Yasuhiro Shiojiri
Makoto Yamada
Toshihiro Takaba
机构
[1] Showa University School of Medicine,First Department of Surgery
关键词
lidocaine; myocardial protection; cardioplegia; cytosolic calcium concentration; heat shock protein;
D O I
10.1007/s11748-003-0057-9
中图分类号
学科分类号
摘要
Objective: During cardiovascular surgery, lidocaine is administered to the cardioplegic system to stabilize cell membrenes and prevent arrhythmia. Lidocaine is also commonly used in hypothermia Both lidocaine and hypothermia are myocardially protective. Under normothermia, lidocaine displays its full pharmacological effects, which are apt, however, to be suppressed under hypothermia. We conducted experiments to determine the optimal temperature for myocardial protection in continuous lidocaine cardioplegia. Methods: In Langendorff mode, rat hearts were continuously perfused with 1 mMol/l of lidocaine solution at 36±0.5°C (Group A), 24±0.5°C (Group B), or 7±0.5°C (Group C) during preservation. Cardiac function and intracellular calcium concentration were measured during both preservation and reperfusion. Heat shock protein 70 (HSP70) was subsequently analyzed by Western blotting. Results: Rapid cardiac arrest was obtained in Groups A and C. Heart rate recovery was good and ultimately the best in Group B, but worst in Group A. During lidocaine perfusion, the volume of coronary perfusion flow decreased gradually in all groups. After reperfusion, Group A showed only a slight increase in coronary perfusion, While Groups B and C showed a marked increase. Left ventricular contractility showed good recovery in all groups. The calcium concentration increased slightly in Group A, but decreased in Groups B and C. No calcium overload was evident in Group A. The same HSP70 level was detected in all groups. Conclusion: Lidocaine used in normothermia does not decrease cardiac metabolism or oxygen consumption, and displays full, pharmacological effectiveness in preventing ischemic injury. We found 36°C to be the optimal temperature for heart preservation by coronary perfusion with lidocaine cardioplegia.
引用
收藏
页码:1 / 9
页数:8
相关论文
共 73 条
[1]  
Inoue K(1979)The evaluation of the myocardial protective effects of various cadioplegic solutions: the experimental studies by isolated working rat hearts J Showa Med Assn 39 143-57
[2]  
Fujiwara H(1987)Improved myocardial protection by pharmacological pretreatment in extended global ischemia based on Mg-lidocaine-induced cardioplegia (Eng abstr) J Jpn Assn Thorac Surg 35 474-82
[3]  
Coyle DE(1987)Bupivacaine and lidocaine blockade of calcium-mediated slow action potential in guinea pig ventricular muscle J Pharmacol Exp Ther 242 1001-5
[4]  
Sperelakis N(2000)Past and present in myocardial protection Ann Thorac Cardiovasc Surg 6 3-8
[5]  
Takaba T(2000)Experimental myocardial preservative study of lidocaine cardioplegia Cardiac structure and metabolism 22 65-70
[6]  
Inoue K(2000)Experimental myocardial preservation study of adding perfluorochemicals (FC43) in lidocaine cardioplegia Jpn J Thorac Cardiovasc Surg 48 280-90
[7]  
Bito A(1987)Role of intracellular Na Exp Anim 36 285-8
[8]  
Inoue K(1989) in Ca Circ Res 65 1045-56
[9]  
Asano M(1983) overload and depressed recovery of ventricular function of reperfused ischemic rat heart Aneth Analg 62 1025-30
[10]  
Ando S(1987)Dissociation constants of local anesthetics and their temperature dependence J Pharm Res 4 42-5